ACRO Biomedical appoints Yu-Ting Su as CEO and chairman; Pao-Chi Chu resigns

ACRO BIOMEDICAL CO., LTD.

Pao-Chi Chu resigned as director, chairman and CEO effective upon successor's appointment; resignation not due to any disagreement.
Board appointed Yu-Ting Su as director, chairman and CEO effective August 14, 2025.
Ms. Su previously served as VP of cell banking division at BioSpring Co., Ltd. (Jan 2023 - Aug 2025) and VP at BioSeed Co., Ltd. (Aug 2020 - Dec 2022).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.